Liqiang Wu

机构：Henan Medical University · ORCID：0000-0002-0463-3521

发表论文 123 篇 · 总被引 1228 次 · h-index 20

代表论文

• FN1 overexpression is correlated with unfavorable prognosis and immune infiltrates in breast cancer (2022 · Frontiers in Genetics · 被引 72)
• Recent advances in combretastatin A-4 codrugs for cancer therapy (2022 · European Journal of Medicinal Chemistry · 被引 38)
• Fully Integrated and High‐Throughput Microfluidic System for Multiplexed Point‐Of‐Care Testing (2024 · Small · 被引 26)
• Multiple on-line active valves based centrifugal microfluidics for dynamic solid-phase enrichment and purification of viral nucleic acid (2024 · Lab on a Chip · 被引 26)
• Research Advances in NQO1-Responsive Prodrugs and Nanocarriers for Cancer Treatment (2022 · Future Medicinal Chemistry · 被引 24)
• On-Line Dual-Active Valves Based Centrifugal Microfluidic Chip for Fully Automated Point-of-Care Immunoassay (2023 · Analytical Chemistry · 被引 21)